Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 220Rectal Neoplasms 137Stomach Neoplasms 95Colonic Neoplasms 87Pancreatic Neoplasms 82Esophageal Neoplasms 71Neoplasm Metastasis 58Squamous Cell Carcinoma of Head and Neck 43Head and Neck Neoplasms 42Adenocarcinoma Of Esophagus 37Neoplasms 36Breast Neoplasms 35Esophageal Squamous Cell Carcinoma 27Carcinoma, Hepatocellular 22Cholangiocarcinoma 21Adenocarcinoma 17Nasopharyngeal Carcinoma 16Bile Duct Neoplasms 14Gallbladder Neoplasms 13Carcinoma, Squamous Cell 13Biliary Tract Neoplasms 13Anus Neoplasms 13Urinary Bladder Neoplasms 11Liver Neoplasms 10Carcinoma 9Nasopharyngeal Neoplasms 8Colorectal Cancer Metastatic 8Peritoneal Neoplasms 7Recurrence 6Ovarian Neoplasms 6

Interventions

Pharmaceutical Preparations 1Irinotecan 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × BRAF V600 Colorectal Cancer × Fluorouracil × Clear all
NCT07150247 2025-09-26

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 2 Recruiting
20 enrolled
Gastrointestinal

BRAF V600 Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡